Team identifies key regulator blocking immunotherapy, paving the way for a new lung cancer treatment
Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to these treatments, highlighting ...
Apr 8, 2025
0
12